Accredited Investors Inc. Medtronic PLC Transaction History

Accredited Investors Inc.

$1.61 Billion
Q1 2025

A detailed history of Accredited Investors Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Accredited Investors Inc. holds 11,963 shares of MDT stock, worth $992,689. This represents 0.07% of its overall portfolio holdings.

Number of Shares

11,963

Previous 11,476 4.24%

Holding current value

$992,689

Previous $916,000 17.25%

% of portfolio

0.07%

Previous 0.06%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$79.84 - $94.5 $38,882 - $46,021	487 Added 4.24%	11,963 $1.07 Million
Q4 2024 Feb 13, 2025	BUY	$79.61 - $92.24 $3,343 - $3,874	42 Added 0.37%	11,476 $916,000
Q3 2024 Nov 06, 2024	BUY	$76.84 - $91.03 $755,029 - $894,460	9,826 Added 611.07%	11,434 $1.03 Million
Q3 2024 Nov 05, 2024	SELL	$76.84 - $91.03 $687,718 - $814,718	-8,950 Reduced 84.77%	1,608 $144,000
Q2 2024 Jul 19, 2024	SELL	$78.71 - $87.02 $61,551 - $68,049	-782 Reduced 6.9%	10,558 $831,000
Q1 2024 May 14, 2024	SELL	$82.84 - $88.09 $4,473 - $4,756	-54 Reduced 0.47%	11,340 $988,000
Q4 2023 Feb 07, 2024	SELL	$69.43 - $83.43 $23,883 - $28,699	-344 Reduced 2.93%	11,394 $938,000
Q3 2023 Nov 07, 2023	BUY	$78.22 - $90.4 $67,894 - $78,467	868 Added 7.99%	11,738 $919,000
Q2 2023 Aug 03, 2023	SELL	$79.47 - $91.38 $70,172 - $80,688	-883 Reduced 7.51%	10,870 $957,000
Q1 2023 Apr 24, 2023	SELL	$76.72 - $87.58 $3,145 - $3,590	-41 Reduced 0.35%	11,753 $947,000
Q4 2022 Feb 07, 2023	SELL	$76.18 - $87.74 $32,985 - $37,991	-433 Reduced 3.54%	11,794 $916,000
Q3 2022 Nov 08, 2022	SELL	$80.75 - $95.31 $196,868 - $232,365	-2,438 Reduced 16.62%	12,227 $987,000
Q2 2022 Jul 21, 2022	SELL	$87.4 - $113.09 $57,684 - $74,639	-660 Reduced 4.31%	14,665 $1.32 Million
Q1 2022 May 06, 2022	BUY	$100.58 - $112.38 $160,123 - $178,908	1,592 Added 11.59%	15,325 $1.7 Million
Q4 2021 Jan 31, 2022	SELL	$99.53 - $127.75 $293,613 - $376,862	-2,950 Reduced 17.68%	13,733 $1.42 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $61,866 - $68,125	-504 Reduced 2.93%	16,683 $2.09 Million
Q2 2021 Jul 30, 2021	SELL	$118.19 - $131.5 $4,845 - $5,391	-41 Reduced 0.24%	17,187 $2.13 Million
Q1 2021 Apr 16, 2021	BUY	$111.18 - $119.74 $789,378 - $850,154	7,100 Added 70.1%	17,228 $2.04 Million
Q4 2020 Feb 11, 2021	SELL	$100.57 - $117.14 $3,519 - $4,099	-35 Reduced 0.34%	10,128 $1.19 Million
Q3 2020 Nov 05, 2020	BUY	$90.13 - $108.78 $144,027 - $173,830	1,598 Added 18.66%	10,163 $1.06 Million
Q2 2020 Jul 29, 2020	SELL	$84.11 - $103.33 $4,121 - $5,063	-49 Reduced 0.57%	8,565 $785,000
Q1 2020 May 15, 2020	BUY	$72.92 - $121.3 $127,610 - $212,275	1,750 Added 25.5%	8,614 $777,000
Q4 2019 Jan 23, 2020	BUY	$104.49 - $114.54 $76,904 - $84,301	736 Added 12.01%	6,864 $779,000
Q3 2019 Nov 14, 2019	SELL	$98.02 - $111.18 $56,753 - $64,373	-579 Reduced 8.63%	6,128 $666,000
Q2 2019 Aug 13, 2019	SELL	$84.15 - $99.38 $22,215 - $26,236	-264 Reduced 3.79%	6,707 $0
Q1 2019 Apr 17, 2019	BUY	$82.45 - $93.79 $66,784 - $75,969	810 Added 13.15%	6,971 $635,000
Q4 2018 Feb 13, 2019	BUY	$85.8 - $99.49 $943 - $1,094	11 Added 0.18%	6,161 $560,000
Q3 2018 Oct 23, 2018	SELL	$85.91 - $99.17 $18,556 - $21,420	-216 Reduced 3.39%	6,150 $605,000
Q2 2018 Jul 31, 2018	SELL	$77.48 - $87.83 $3,254 - $3,688	-42 Reduced 0.66%	6,366 $545,000
Q1 2018 Apr 18, 2018	BUY	$76.55 - $87.26 $67,364 - $76,788	880 Added 15.92%	6,408 $514,000
Q4 2017 Jan 17, 2018	BUY	$76.93 - $83.5 $62,313 - $67,635	810 Added 17.17%	5,528 $446,000
Q3 2017 Oct 30, 2017	BUY	$77.71 - $84.6 $366,635 - $399,142	4,718	4,718 $367,000

Others Institutions Holding MDT

# of Institutions

2,448

Shares Held

1.06B

Call Options Held

10.3M

Put Options Held

9.61M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $110B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.

Account

Accredited Investors Inc. Medtronic PLC Transaction History